Increased dose-density (DD) Is feasible: A pilot study of epirubicin and cyclophosphamide (EC) followed by paclitaxel (T), at 10–11 day interval with filgrastim support, for women with early breast carcinoma (BC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. N. Fornier, A. D. Seidman, D. Lake, G. D’Andrea, J. Bromberg, M. Robson, C. H. van Poznak, K. Panageas, L. Norton, C. Hudis
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2590325960